|
|
|
Volumn 28, Issue 2, 1996, Pages 985-986
|
|
A randomized, double-blind, placebo-controlled study to determine safety, tolerance, and preliminary pharmacokinetics of ascending single doses of orally administered sirolimus (rapamycin) in stable renal transplant recipients
a
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
AZATHIOPRINE;
CREATININE;
CYCLOSPORIN A;
PREDNISOLONE;
RAPAMYCIN;
ADULT;
AGED;
AREA UNDER THE CURVE;
CLINICAL ARTICLE;
CLINICAL TRIAL;
CONFERENCE PAPER;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
DOSE RESPONSE;
DOUBLE BLIND PROCEDURE;
DRUG BLOOD LEVEL;
DRUG SAFETY;
DRUG TOLERANCE;
EPISTAXIS;
FEMALE;
HEADACHE;
HUMAN;
HYPOGLYCEMIA;
IMMUNOSUPPRESSIVE TREATMENT;
INTRAVENOUS DRUG ADMINISTRATION;
KIDNEY TRANSPLANTATION;
MALE;
NAUSEA;
ORAL DRUG ADMINISTRATION;
PHASE 1 CLINICAL TRIAL;
PRIORITY JOURNAL;
RANDOMIZED CONTROLLED TRIAL;
THROMBOCYTOPENIA;
VERTIGO;
ADULT;
AGED;
AZATHIOPRINE;
CYCLOSPORINE;
DOSE-RESPONSE RELATIONSHIP, DRUG;
DOUBLE-BLIND METHOD;
DRUG THERAPY, COMBINATION;
FEMALE;
HUMANS;
IMMUNOSUPPRESSIVE AGENTS;
KIDNEY TRANSPLANTATION;
MALE;
MIDDLE AGED;
PLACEBOS;
POLYENES;
PREDNISOLONE;
SIROLIMUS;
|
|
EID: 0029922065
PISSN: 00411345
EISSN: None
Source Type: Journal
DOI: None Document Type: Conference Paper |
|
Times cited : (37)
|
|
References (0)
|
